Home › Funds › Norges Bank Investment Management › NMRA
Norges Bank Investment Management position in NMRA
NEUMORA THERAPEUTICS INC. · Health Care
Latest position (Q4 2024)110.00K sh
Reported value held$1.17M
Portfolio Weight0.00%
First reportedQ4 2023
Last changeHold
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q4 2023 | 50.00K | $852.50K | New |
| Q2 2024 | 110.00K | $1.08M | Add |
| Q4 2024 | 110.00K | $1.17M | Hold |
Dots on the line are colored by change type; missing quarters mean no position was reported.
Other funds holding NMRA
- BlackRock Inc 7.79M sh · $13.25M · Q2 2026
- Vanguard Group 4.54M sh · $8.13M · Q4 2025
- Fidelity Management & Research (FMR) 3.50M sh · $5.95M · Q2 2026
- Geode Capital Management 2.61M sh · $4.43M · Q2 2026
- Two Sigma Investments 2.24M sh · $3.82M · Q2 2026
- Renaissance Technologies 1.26M sh · $2.15M · Q2 2026
- Citadel Advisors 1.07M sh · $1.82M · Q2 2026
- Marshall Wace 904.46K sh · $1.54M · Q2 2026
- Charles Schwab Investment Management 823.58K sh · $1.40M · Q2 2026
- Northern Trust Corp 800.57K sh · $1.36M · Q2 2026
- Millennium Management 509.21K sh · $865.66K · Q2 2026
- Morgan Stanley 319.42K sh · $543.02K · Q2 2026